Press Releases

NDA Group announces Christine Lind as the new VP of Commercial

NDA Group, a world-leading regulatory, drug development and medical device consultancy, has appointed Christine Lind as the new VP of Commercial.

Sygnature Discovery expands US presence with office in Bay Area biotech hub

Sygnature Discovery, a world-leading integrated drug discovery and non-clinical solutions provider, has expanded its US presence with a new office in South San Francisco’s biotech hub at Oyster Point.

GenNext Technologies Announces NIH Grant Funding of Nearly $7M Leads to a Seminal Protein Footprinting Patent

GenNext Technologies, Inc., a growth-stage company that provides instrumentation, software and services to structural biology researchers within the biopharmaceutical industry, announced today that nearly $7M (US) in NIH grant awards has led to a seminal US patent for its novel technology.

DefiniGEN appoints Dr Ben Cons as Chairman of its Board

DefiniGEN, the world leader in human induced pluripotent stem cell (iPSC) differentiation and disease modelling, has announced the appointment of Dr Ben Cons as Chairman of the Board.

EchelonDx and Cradle Genomics Join Forces to Accelerate Development of Comprehensive Non-Invasive Prenatal Diagnostic Products

Echelon Diagnostics and Cradle Genomics today announced an agreement that will help accelerate the development of Cradle’s innovative cellular-based non-invasive prenatal diagnostic (NIPD) products.

Thermo Fisher Scientific Launches First-Ever GMP- and Cleanroom-Compatible CO2 Incubator

Thermo Fisher Scientific announced today the launch of the Thermo Scientific Heracell Vios CR CO2 Incubator that is designed to address the need of biotechnology, biopharmaceutical and clinical laboratories for high-performance systems that meet stringent cleanroom and cGMP standards.

Takara Bio Europe AB and PanCryos Announce Licensing Agreement to Enable Development of Cell-Based Therapy for Diabetes

Takara Bio Europe AB (TBEAB) has announced a licensing agreement with PanCryos, a pre-clinical stage biotech company.

MicrobioSeq Introduces Microbial Iso-Seq to Characterize the Diverse Landscape of Transcript Isoforms

Microbiosci Provides Microbial Metabolomics Services with Advanced Instruments and State-of-the-art Multivariate Data Analyses

Bioinformatics-Analysis Division of CD Genomics Introduces Single Cell Genome Analysis Services

British digital health start-up launches free app to help improve inhaler technique and reduce asthma attacks

Introducing Clip-Tone Buddy app to aid inhaler technique.

Cytel Announces New VP Scientific Strategy & Innovation to Further Drive Bayesian Innovation

Cytel Inc. has appointed renowned Bayesian clinical trial design specialist Dr Kyle Wathen as Vice President of Scientific Strategy and Innovation.

Sygnature Discovery appoints Dr. David Lustig to spearhead US expansion

Sygnature Discovery, a world-leading integrated drug discovery and non-clinical solutions provider, has appointed Dr. David Lustig to the role of Vice President Business Development - United States.

Biological Specialty Company Opens New Blood Donor Center in HealthStar Physicians Practice

New partnership will allow HealthStar patients to make important contributions toward advancing medical research.

Vaccine Passports in NHS app unethical if they don’t allow date custodianship say FarmaTrust

Blockchain, not the NHS app, is the obvious overlooked answer to security and custodianship

Alfa Chemistry Launches a Subsidiary Website for Nanomaterials

BOC Sciences Provides Ultra-sensitive Cyanine Dyes for Biofluorescence Labeling

Lonza Launches Next Generation 4D-Nucleofector Cell Transfection Platform with Proven Performance and Enhanced Ease of Use

Lonza has today announced the launch of the next generation 4D-Nucleofector® Cell Transfection Platform.

EIT Health’s S4DX raises 5 million euros to digitise blood sampling

Indica Labs and Ibex Partner to Deliver AI-powered Clinical Workflows for Digital Pathology

Indica Labs, an industry leader in quantitative digital pathology & image management solutions, has announced an agreement with Ibex Medical Analytics, a pioneer in artificial intelligence (AI) based cancer diagnostics, to integrate the Galen™ AI-based cancer diagnostics platform into the HALO AP® digital pathology workflow platform.